English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 903472 Online Users : 307
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
感染症與疫苗研究所
周彥宏
--報告
--專利
--期刊論文
--圖書
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
感染症與疫苗研究所
>
周彥宏
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Collection
報告
[
0
/1]
專利
[
0
/10]
期刊論文
[
46
/46]
圖書
[
0
/1]
Siblings
余佳益
[
17
/17]
余冠儀
[
40
/40]
冷治湘
[
61
/89]
劉士任
[
121
/149]
劉家齊
[
45
/52]
司徒惠康
[
71
/72]
吳綺容
[
84
/84]
宋旺洲
[
33
/34]
廖經倫
[
32
/32]
張仲明
[
2
/2]
張堯
[
44
/44]
曾凡真
[
34
/34]
曾才騰
[
9
/9]
李敏西
[
60
/64]
杜鴻運
[
50
/50]
楊采菱
[
133
/134]
潘建雄
[
18
/19]
羅秀容
[
96
/97]
胡勇誌
[
23
/23]
莊再成
[
104
/153]
蕭樑基
[
158
/161]
蘇益仁(2002-2015)
[
190
/195]
許修誌(2005-2010)
[
1
/1]
許素菁
[
27
/30]
謝鐸源(2006-2014)
[
20
/27]
郭書辰
[
139
/141]
陳俊宏
[
61
/62]
陳信偉
[
83
/110]
陳宜君
[
38
/38]
陳逢叡
[
40
/40]
黃明熙
[
51
/64]
黃盈綺
[
6
/6]
齊嘉鈺
[
46
/46]
McDonald LC(1998-2000)
[
12
/12]
何曼德(1997-2002)
[
38
/39]
其他
[
177
/177]
朱清良(2005-2007)
[
4
/4]
梁蘭蘭(1998-2006)
[
6
/6]
黃崑巖(1999-2004)
[
4
/4]
Community Statistics
近3年內發表的文件:8(13.79%)
含全文筆數:46(79.31%)
文件下載次數統計
下載大於0次:46(100.00%)
下載大於100次:44(95.65%)
檔案下載總次數:25299(0.47%)
最後更新時間: 2024-12-01 00:30
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Hyperglycemia facilitates EV71 repl...
The stability and immunogenicity of...
Human SCARB2 acts as a cellular ass...
Propagation and immunological chara...
Separation and purification of high...
SARS-CoV-2 spike protein enhances M...
Neurotropic EV71 causes encephaliti...
作為對抗腸病毒感染之免疫原的病毒顆粒及其製造
作为对抗肠病毒感染之免疫原的病毒颗粒及其制造
エンテロウイルス感染に対する免疫原としてのウイルス粒子およびその生産(...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-50 of 58. (2 Page(s) Totally)
1
2
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2024-04-22
Hyperglycemia facilitates EV71 replication: Insights into miR-206-mediated regulation of G3BP2 promoting EV71 IRES activity
Theranostics. 2024 Apr 22;14(7):2706-2718.
2023-12
The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage
Journal of Microbiology, Immunology and Infection. 2023 Dec;56(6):1121-1128.
2023-04-08
Human SCARB2 acts as a cellular associator for helping coxsackieviruses A10 infection
Viruses. 2023 Apr 8;15(4):Article number 932.
2023-03-24
Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system
Virus Research. 2023 Mar 24;329:Article number 199101.
2022-09-13
Separation and purification of highly infectious enterovirus A71 particles using a strong anion-exchange column
Journal of Chromatography A. 2022 Sep 13;1680:Article number 463427.
2022-07-27
SARS-CoV-2 spike protein enhances MAP4K3/GLK-induced ACE2 stability in COVID-19
EMBO Molecular Medicine. 2022 Jul 27:Article number e15904.
2022-04-11
Neurotropic EV71 causes encephalitis by engaging intracellular TLR9 to elicit neurotoxic IL12-p40-iNOS signaling
Cell Death and Disease. 2022 Apr 11;13:Article number 328.
2022-01-28
Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein
Vaccine. 2022 Jan28;40(4):574-586.
2021-01-26
作为对抗肠病毒感染之免疫原的病毒颗粒及其制造
CN106661102B/2021-01-26
2020-10-21
エンテロウイルス感染に対する免疫原としてのウイルス粒子およびその生産(Viral particles and their production as immunogens against enterovirus infection)
JP6774149B2/2020-10-21
2020-03-02
作為對抗腸病毒感染之免疫原的病毒顆粒及其製造
I688652/2020-03-02
2019-01
The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus
PLoS ONE. 2019 Jan;14(1):Article number e0210553.
2018-08
Maternal immunization with a recombinant adenovirus-expressing fusion protein protects neonatal cotton rats from respiratory syncytia virus infection by transferring antibodies via breast milk and placenta
Virology. 2018 Aug;521:181-189.
2018-07-16
A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
Scientific Reports. 2018 Jul 16;8:Article number 10713.
2018-07
Therapeutic effect of repurposed temsirolimus in lung adenocarcinoma model
Frontiers in Pharmacology. 2018;9:Article number 778
2018-06-04
Mutations in VP1 and 5′-UTR affect enterovirus 71 virulence [Erratum: Scientific Reports. 2018 Apr 27;8(1):Article number 6688.]
Scientific Reports. 2018 Jun 4;8:Article number 8744.
2018-05
Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture
Vaccine. 2018 May;36(22):3134-3139.
2018-04-27
Mutations in VP1 and 5′-UTR affect enterovirus 71 virulence
Scientific Reports. 2018 Apr 27;8(1):Article number 6688.
2017-04-18
Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype
PLoS ONE. 2017 Apr 18;12(4):Article number e0175586.
2016-08
Insulin Receptor Substrate-1 activation mediated p53 downregulation protects against Hypoxic-Ischemia in the neonatal brain
Molecular Neurobiology. 2016 Aug;53(6):3658-3669.
2016-08
Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology
Antiviral Research. 2016 Aug;132:225-232.
2016-06
Immunogenicity of an adeno-vector vaccine expressing the F protein of a respiratory syncytial virus manufactured from serum-free suspension culture
Antiviral Research. 2016 Jun;130:27-35.
2016-05
Immunological and biochemical characterizations of Coxsackievirus A6 and A10 viral particles
Antiviral Research. 2016 May;129:58-66.
2015-12
Depletion of regulatory T-cells leads to moderate B-cell antigenicity in respiratory syncytial virus infection
International Journal of Infectious Diseases. 2015 Dec;41:56-64.
2015-09-16
hSCARB2基因转殖鼠的制造及其做为肠病毒感染动物模式的应用
ZL201110397498.6/2015-09-16
2015-08-19
Inactivated enterovirus 71 vaccine produced by 200-L scale serum-free microcarrier bioreactor system provides cross-protective efficacy in human SCARB2 transgenic mouse
PLoS ONE. 2015 Aug 19;10(8):Article number e0136420.
2015-08-04
Human respiratory syncytial virus (RSV) vaccine
2015-08-04.
2015-04
Recombinant adeno-vaccine expressing Enterovirus 71-like particles against hand, foot, and mouth disease
PLoS Neglected Tropical Diseases. 2015 Apr;9(4):Article number e0003692.
2015-03
Review of enterovirus 71 vaccines
Clinical Infectious Diseases. 2015 Mar;60(5):797-803.
2014-10
Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes
Antiviral Research. 2014 Oct;110:124-131.
2014-10
Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases
Vaccine. 2014 Oct;32(47):6177-6182.
2014-09-08
Long-term immunogenicity studies of formalin-inactivated Enterovirus 71 whole-virion vaccine in macaques
PLoS ONE. 2014 Sep 8;9(9):Article number e106756.
2014-09
Epstein-barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma
Oncotarget. 2014 Sep;5(18):8583-8601.
2014-06-11
Immunogenicity studies of bivalent Inactivated virions of EV71/CVA16 formulated with submicron emulsion systems
Biomed Research International. 2014 Jun 11;2014:Article number 670506.
2014-04-01
hSCARB2基因轉殖鼠之製造及其做為腸病毒感染動物模式之應用
I432576/2014-04-01
2013-12-21
多價嵌合型德國麻疹載體病毒疫苗
I419968/2013-12-21
2013-11-21
人類呼吸道融合病毒(RSV)疫苗
I415939/2013-11-21
2013-10-02
Heat Shock protein 90: Role in enterovirus 71 entry and assembly and potential target for therapy
PLoS ONE. 2013 Oct 2;8(10):Article number e77133.
2013-08
Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection
Journal of Virology. 2013 Aug;7(16):9064-9076.
2013-07-30
Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice
PLoS ONE. 2013 Jul 30;8(7):Article number e69858.
2013-06-11
Polyvalent chimeric rubella virus-based vaccines
US8460680B2/2013-06-11
2013-02-25
Human SCARB2 transgenic mice as an infectious animal model for Enterovirus 71
PLoS ONE. 2013 Feb 25;8(2):Article number e57591.
2013-02-01
肺癌之非人類實驗動物模式
I384068/2013-02-01
2012-12
Production of EV71 vaccine candidates
Human Vaccine Immunotherapy. 2012 Dec;8(12):1775-1783.
2012-09
Immunological evaluation and comparison of different EV71 vaccine candidates
Clinical and Developmental Immunology. 2012 Sep;2012:Article ID 831282.
2012-07-31
Non-human animal model for lung carcinoma
US8232446B2/2012-07-31
2012-04
Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates
PLoS ONE. 2012 Apr;7(4):Article number e34834.
2012-01
Human SCARB2-Mediated entry and endocytosis of EV71
PLoS ONE. 2012 Jan;7(1):Article number e30507.
2011-09
Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process
Journal of Virological Methods. 2011 Sep;176(1-2):60-68.
2011-09
Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse
PLoS ONE. 2011 Sep;6(9):Article number e25500.
Showing items 1-50 of 58. (2 Page(s) Totally)
1
2
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback